Looker Benjamin Insider Trades

Insider Trading History

Track insider trading activity for Looker Benjamin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Esperion Therapeutics
Esperion Therapeutics ESPR
Chief Legal Officer
Holding Value $2.11M 667,524 shares
Last Trade
Jun 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.4k 11,824 shares
$3.16
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
Chief Legal Officer
Holding Value $2.15M 679,348 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$15.4k 5,708 shares
$2.70
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
Chief Legal Officer
Holding Value $2.16M 685,056 shares
Last Trade
Mar 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.39M 570,070 shares
$2.44
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $1.21M 384,216 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.86k 1,689 shares
$2.88
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $1.22M 385,905 shares
Last Trade
Dec 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$23.9k 6,517 shares
$3.67
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $1.24M 393,670 shares
Last Trade
Sep 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.5k 6,267 shares
$2.80
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $1.26M 399,937 shares
Last Trade
Jul 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.47k 1,304 shares
$1.13
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $1.27M 401,241 shares
Last Trade
Jun 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.39k 6,422 shares
$1.15
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $1.29M 407,663 shares
Last Trade
Mar 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$302k 201,000 shares
$1.50
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $580k 183,663 shares
Last Trade
Mar 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$308k 150,000 shares
$2.05
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $264k 83,663 shares
Last Trade
Apr 19, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.64k 1,290 shares
$1.27
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $275k 86,900 shares
Last Trade
Mar 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$432k 107,400 shares
$4.02
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $204k 64,453 shares
Last Trade
Jan 18, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$44.4k 6,347 shares
$7.00
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $164k 52,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$322k 52,000 shares
$6.20
$3.16
Esperion Therapeutics
Esperion Therapeutics ESPR
General Counsel
Holding Value $317k 100,450 shares
Last Trade
Jan 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$625k 171,250 shares
$3.65
$3.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up